Literature DB >> 7477847

Spatial data analysis in the quantitative assessment of cerebral white matter pathology on MRI in HIV infection.

R J Corrigall1, W K Chong, M Paley, I D Wilkinson, P Lantos, I Everall.   

Abstract

This study was carried out using MRI (proton density--and T2-weighted) on 16 HIV-negative controls, 9 symptom-free HIV-positive patients and 25 with CDC IV HIV disease. The studies from this last group had previously been allocated by a radiologist to the following categories: 8 with focal mass lesions and normal-appearing white matter; 9 with diffuse encephalopathy (high signal on T2-weighted images, affecting most or all of the white matter) and 8 with patchy encephalopathy (high signal affecting only one or two areas within the white matter). Moran's I, a statistic of spatial autocorrelation, was calculated for the grey-scale values of a sampled pixel array from a central white matter region of each of the images. All values of Moran's I calculated in this study showed a large positive excess over the expected value under randomisation, indicating highly significant positive auto-correlation in the spatial arrangement of the grey-scale values. On T2-weighted images a statistically significant increase in the mean value of Moran's I, compared with controls, was found in the diffuse encephalopathy group, indicating that quantifiable changes in the spatial autocorrelation of pixel data can be related to recognised qualitative changes in the appearance of white matter in subjects with HIV disease. A lesser, but significant, rise in the mean value of Moran's I was also found in the focal mass lesion group, suggesting that changes in spatial autocorrelation may indicate pathological change in advance of qualitative MRI changes.

Entities:  

Mesh:

Year:  1995        PMID: 7477847     DOI: 10.1007/bf00600081

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  Towards quantitative measurements of relaxation times and other parameters in the brain.

Authors:  P S Tofts; E P du Boulay
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation.

Authors:  H S Chrysikopoulos; G A Press; M R Grafe; J R Hesselink; C A Wiley
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

3.  The definition of HIV-specific neuropathology.

Authors:  H Budka
Journal:  Acta Pathol Jpn       Date:  1991-03

4.  Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review.

Authors:  C K Petito; E S Cho; W Lemann; B A Navia; R W Price
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

Review 5.  CNS complications of AIDS: CT and MR findings.

Authors:  R G Ramsey; G K Geremia
Journal:  AJR Am J Roentgenol       Date:  1988-09       Impact factor: 3.959

6.  Acquired immune deficiency syndrome and multiple tract degeneration in a homosexual man.

Authors:  D S Horoupian; P Pick; I Spigland; P Smith; R Portenoy; R Katzman; S Cho
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

7.  White matter disease in AIDS: findings at MR imaging.

Authors:  W L Olsen; F M Longo; C M Mills; D Norman
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

8.  Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging.

Authors:  D J Meyerhoff; S MacKay; L Bachman; N Poole; W P Dillon; M W Weiner; G Fein
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

9.  Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis.

Authors:  G J Dal Pan; J H McArthur; E Aylward; O A Selnes; T E Nance-Sproson; A J Kumar; E D Mellits; J C McArthur
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

10.  Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS).

Authors:  P Kleihues; W Lang; P C Burger; H Budka; M Vogt; R Maurer; R Lüthy; W Siegenthaler
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.